Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis

• Market Cap: ¥12.90B
• Dividend Yield: 3.14%
• Average Volume (3M): 78.04K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.47
• Revenue Growth: 3.59%
• EPS Growth: -163.09%
• Country: JP
• Employees: 511
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 0.15
• Shares Outstanding: 26,475,880
• 10 Day Avg. Volume: 64,910
• 30 Day Avg. Volume: 78,036
• PEG Ratio: 0.24
• Price to Book (P/B): 0.61
• Price to Sales (P/S): 0.60
• P/FCF Ratio: -29.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: ¥538.00 ▲(4.47% Upside)

The overall stock score of 58 reflects the company's stable revenue growth and strong balance sheet, offset by profitability challenges and negative free cash flow. Technical indicators suggest a neutral trend with potential risks of a pullback. Valuation is impacted by negative earnings, but the dividend yield offers some investor appeal.

Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model

Company Description

Japan Medical Dynamic Marketing, Inc. (7600) is a leading healthcare company based in Japan, specializing in the distribution and marketing of medical devices and pharmaceuticals. The company operates primarily in the medical technology sector, focusing on innovative solutions that enhance patient care and improve healthcare outcomes. Its core products include advanced medical equipment, diagnostic tools, and therapeutic devices aimed at hospitals and healthcare providers across the nation.

How the Company Makes Money

Japan Medical Dynamic Marketing, Inc. generates revenue through multiple streams, primarily from the sales of its medical devices and pharmaceuticals to hospitals and clinics. The company partners with various manufacturers to distribute their products, earning a margin on sales. Additionally, it may generate income through service contracts for maintenance and support of its medical equipment. Other revenue streams could include consulting services related to product implementation and training for healthcare professionals. Strategic collaborations with healthcare institutions and participation in government healthcare initiatives further bolster its earnings potential.

Japan Medical Dynamic Marketing, Inc. Financial Statement Overview

Summary

The company shows stable revenue growth but faces profitability challenges with a negative net income in 2025. The balance sheet is strong with low leverage, but negative free cash flow raises concerns about liquidity and funding operations.

Income Statement

The company experienced a moderate revenue growth rate over recent years, with a notable increase from 2024 to 2025. However, the net profit margin turned negative in 2025, indicating profitability challenges. Gross profit margins have remained relatively stable, but declining EBIT and EBITDA margins suggest rising operational costs.

Balance Sheet

The balance sheet shows a strong equity base with a healthy equity ratio, demonstrating financial stability. The debt-to-equity ratio is relatively low, indicating conservative leverage. However, a decrease in stockholders' equity in 2025 could be a concern if it continues.

Cash Flow

Free cash flow has fluctuated, turning negative in 2025, which might impact liquidity. The operating cash flow to net income ratio shows adequate cash conversion, but the negative free cash flow raises concerns about the company's ability to fund operations and growth without external financing.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	24.98B	25.11B	23.18B	21.31B	19.19B	16.74B
Gross Profit	14.46B	15.65B	14.76B	13.99B	12.99B	11.42B
EBITDA	1.03B	1.40B	3.27B	3.35B	4.21B	3.47B
Net Income	-669.47M	-461.80M	1.27B	1.42B	2.14B	1.66B
Balance Sheet
Total Assets	32.22B	33.67B	31.49B	29.43B	27.34B	25.19B
Cash, Cash Equivalents and Short-Term Investments	2.35B	3.18B	2.32B	2.80B	2.59B	2.47B
Total Debt	4.31B	3.29B	1.49B	1.87B	1.85B	3.09B
Total Liabilities	8.25B	8.93B	5.88B	6.14B	5.85B	6.48B
Stockholders Equity	23.96B	24.68B	25.51B	23.16B	21.39B	18.63B
Cash Flow
Free Cash Flow	0.00	-504.10M	302.45M	870.67M	1.53B	1.23B
Operating Cash Flow	0.00	1.05B	2.10B	2.19B	3.11B	2.60B
Investing Cash Flow	0.00	-1.67B	-1.80B	-1.48B	-1.75B	-1.35B
Financing Cash Flow	0.00	1.49B	-840.71M	-514.78M	-1.29B	-1.31B

Japan Medical Dynamic Marketing, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 515.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Negative. The current price of 515 is above the 20-day moving average (MA) of 511.60, above the 50-day MA of 513.68, and below the 200-day MA of 550.14, indicating a bearish trend. The MACD of -3.24 indicates Positive momentum. The RSI at 34.29 is Neutral, neither overbought nor oversold. The STOCH value of 8.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7600.

Japan Medical Dynamic Marketing, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5187	―	¥9.27B	12.43	―	3.59%	3.38%	88.65%
6678	―	¥15.98B	15.50	―	3.62%	-8.07%	-38.21%
7963	―	¥9.19B	11.88	―	1.88%	9.07%	43.42%
7792	―	¥13.50B	10.76	―	2.83%	12.36%	38.55%
7600	―	¥12.90B	―	―	3.14%	3.59%	-163.09%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
7777	―	$34.74B	-31.75	-49.32%	―	45.67%	29.44%

Japan Medical Dynamic Marketing, Inc. Corporate Events

Japan Medical Dynamic Marketing Revises Earnings Forecasts Amid Supply Challenges

Japan Medical Dynamic Marketing, Inc. has revised its earnings forecasts for the second quarter and full fiscal year ending March 31, 2026, due to ongoing supply constraints affecting artificial knee joint products in the U.S. This has led to a temporary slowdown in surgeries in Japan and the U.S., impacting sales and profits. The company is addressing these challenges by optimizing its supply chain, reviewing staffing plans, and enhancing in-house manufacturing capabilities to improve profitability in the medium term. Despite the downward revision in earnings forecasts, the company plans to maintain its dividend payout, prioritizing stable profit distribution to shareholders.

The most recent analyst rating on (JP:7600) stock is a Hold with a Yen565.00 price target. To see the full list of analyst forecasts on Japan Medical Dynamic Marketing, Inc. stock, see the JP:7600 Stock Forecast page.

Japan Medical Dynamic Marketing Reports Q1 Financial Decline Amidst Market Challenges

Japan Medical Dynamic Marketing, Inc. reported a decline in its financial performance for the first quarter of the fiscal year ending March 2026, with significant drops in net sales, operating profit, and profit attributable to owners of the parent compared to the previous year. Despite the downturn, the company maintains a strong capital adequacy ratio and has not revised its financial forecasts, suggesting a cautious optimism about future performance.